Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study
Abstract Background Building on the declining trend of malaria in Ethiopia, the Federal Ministry of Health aims to eliminate malaria by 2030. As Plasmodium falciparum and Plasmodium vivax are co-endemic in Ethiopia, the use of primaquine is indicated for both transmission interruption and radical cu...
Main Authors: | Ashenafi Assefa, Ahmed Ali, Wakgari Deressa, Wendimagegn Tsegaye, Getachew Abebe, Heven Sime, Amha Kebede, Daddi Jima, Moges Kassa, Tesfay Abreha, Hiwot Teka, Hiwot Solomon, Joseph Malone, Ya Ping Shi, Zhiyong Zhou, Richard Reithinger, Jimee Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12936-018-2538-4 |
Similar Items
-
Simplified and Rapid Determination of Primaquine and 5,6-Orthoquinone Primaquine by UHPLC-MS/MS: Its Application to a Pharmacokinetic Study
by: Waritda Pookmanee, et al.
Published: (2021-07-01) -
Glusoce-6-phosphate dehydrogenase- History and diagnosis
by: K Gautam
Published: (2016-09-01) -
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
by: Sara Avalos, et al.
Published: (2018-11-01) -
The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
by: Lek Dysoley, et al.
Published: (2019-03-01) -
Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study.
by: Desalegn Nega, et al.
Published: (2016-01-01)